Health Technology · Pharmaceuticals: Major · NSE: AMANTA · data 2026-10-09

Amanta Healthcare Limited

Health check: Average (5.4/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹187.42

Market cap

₹761 cr

P/E

49.6

P/B

—

ROE

9.4%

ROCE

11.5%

Debt / equity

1.11

Dividend yield

0.00%

1-year return

38.8%

52-week high

₹209.95

52-week low

₹92

Operating margin

14.0%

Growth

Revenue (last 12 months)	₹291 cr
Net profit (last 12 months)	₹15 cr
Sales growth, 3 years (yearly)	3.5%
Profit growth, 3 years (yearly)	—

Chart patterns

Double top — forming (key level ₹183.47)

Similar companies

Shree Ganesh Remedies Ltd. (SGRL) · Kilitch Drugs (India) Limited (KILITCH) · Hexagon Nutrition Limited (HEXAGON) · Anuh Pharma Limited (ANUHPHR) · Wanbury Limited (WANBURY)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AMANTA in NSE Scanner →